Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 41757398
Tirzepatide Combined With Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnoea Syndrome With Comorbid Obesity: Effects on Weight, Daytime Sleepiness, and Cognitive Performance.
Diabetes, obesity & metabolism
2026
PMID: 41757398
View on PubMed
DOI: 10.1111/dom.70604
Tirzepatide
Authors
Fernandes, Mariana; Antonucci, Matteo; Testone, Greta; Bergamo, Giusy; Liguori, Claudio
Keywords
GIP
GLP‐1
patient reported outcomes
real‐world evidence
weight management
Tirzepatide Combined With Continuous Positive Airway Pressure Treatment in Obstructive Sleep Apnoea Syndrome With Comorbid Obesity: Effects on Weight, Daytime Sleepiness, and Cognitive Performance. | Pepdox